Basic Information
Basic information for NR2F1-AS1-224-35aa
Peptide Name NR2F1-AS1-224-35aa
Genome Position chr5:93580588-93580692[-]
Species Human
Peptide Sequence MILLLVTYSPIAYSHPPRFEIAPLGRLRRARSRAE
Peptide Length 35
Unique No (NR2F1-AS1-208-35aa,NR2F1-AS1-216-35aa,NR2F1-AS1-226-35aa,NR2F1-AS1-240-35aa,NR2F1-AS1-241-35aa,NR2F1-AS1-244-35aa,NR2F1-AS1-245-35aa,NR2F1-AS1-251-35aa,NR2F1-AS1-254-35aa,NR2F1-AS1-259-35aa,NR2F1-AS1-266-35aa,NR2F1-AS1-268-35aa,NR2F1-AS1-274-35aa)
Grand Average of Hydropathicity -0.0314
Relative Molecular Mass 4664.29
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000237187;NR2F1-AS1
Transcript ID/Name ENST00000654055;NR2F1-AS1-224
Transcript Length 3530
Coding Ability 0.3567
DNA Sequence Corresponding to Peptide ATGATACTTCTATTAGTTACATATTCTCCAATCGCATACTCGCACCCCCCTCGTTTTGAGATCGCTCCCCTAGGCAGGCTCAGGCGGGCGCGGAGCCGCGCGGAG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :